Evidence map›Paper›PMID 28480342›Full record

ArticleInvestigative and clinical urology2017

A preliminary oncologic outcome and postoperative complications in patients undergoing robot-assisted radical cystectomy: Initial experience.

Satoru Muto, Kousuke Kitamura, Takeshi Ieda, Fumitaka Shimizu, Masayoshi Nagata, Shuji Isotani, Hisamitsu Ide, Raizo Yamaguchi, Shigeo Horie

Open access · diamondAbstract read
In one paragraph

Article in Investigative and clinical urology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Revolutionary Advances of Robotic Surgery in Urology Field.Juntendo Iji zasshi = Juntendo medical journal · 2024
    Review
  5. Single staff cystectomy in a low-volume center: Oncological outcomes and complications.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2021
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Satoru MutoDepartment of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Kousuke KitamuraDepartment of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Takeshi IedaDepartment of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Fumitaka ShimizuDepartment of Urology, Juntendo Nerima Hospital, Tokyo, Japan.
Masayoshi NagataDepartment of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Shuji IsotaniDepartment of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hisamitsu IdeDepartment of Urology, Teikyo University School of Medicine, Tokyo, Japan.
Raizo YamaguchiDepartment of Urology, Teikyo University School of Medicine, Tokyo, Japan.
Shigeo HorieDepartment of Urology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Juntendo University · JPTeikyo University · JPJuntendo University Nerima Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeRobot-assisted radical cystectomy (RARC) was originally intended to replace open radical cystectomy (ORC) as a minimally invasive surgery for patients with invasive bladder cancer. The purpose of this study was to evaluate the advantages of robotic surgery, comparing perioperative and oncologic outcomes between RARC and ORC. MATERIALS AND

methodsBetween June 2012 and August 2016, 49 bladder cancer patients were given a radical cystectomy, 21 robotically and 28 by open procedure. We compared the clinical variables between the RARC and ORC groups.

resultsIn the RARC group, the median estimated blood loss (EBL) during cystectomy, total EBL, operative time during cystectomy, and total operative time were 0 mL, 457.5 mL, 199 minutes, and 561 minutes, respectively. EBL during cystectomy (p<0.001), total EBL (p<0.001), and operative time during cystectomy (p=0.003) in the RARC group were significantly lower compared with the ORC group. Time to resumption of a regular diet (p<0.001) and length of stay (p=0.017) were also significantly shorter compared with the ORC group. However, total operative time in the RARC group (median, 561 minutes) was significantly longer compared with the ORC group (median, 492.5 minutes; p=0.015).

conclusionsThis Japanese study presented evidence that RARC yields benefits in terms of BL and time to regular diet, while consuming greater total operative time. RARC may be a minimally invasive surgical alternative to ORC with less EBL and shorter length of stay.

Indexed as

AgedBlood Loss, SurgicalCystectomyFemaleHumansLength of StayMaleOperative TimePostoperative ComplicationsRobotic Surgical ProceduresTreatment OutcomeUrinary Bladder NeoplasmsCystectomyRoboticsUrinary bladder neoplasms

Identifiers

PMID28480342
PMCPMC5419105
OpenAlexW2611730644

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.